Author:
Liu Xiaoqian,Zhang Siyuan,Wang Dong,Lv Kaili,Wang Yonggui,Peng Lei
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Katoh, M. & Katoh, M. Identification and characterization of ARHGAP24 and ARHGAP25 genes in silico. Int. J. Mol. Med. 14, 333–338 (2004).
2. Tao, L., Gu, Y., Zheng, J., Yang, J. & Zhu, Y. Weichang’an suppressed migration and invasion of HCT116 cells by inhibiting Wnt/beta-catenin pathway while upregulating ARHGAP25. Biotechnol. Appl. Biochem. 66, 787–793 (2019).
3. Tao, L., Zhu, Y., Gu, Y., Zheng, J. & Yang, J. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/beta-catenin pathway. Eur. J. Pharmacol. 858, 172476 (2019).
4. Xu, K., Liu, B. & Ma, Y. The tumor suppressive roles of ARHGAP25 in lung cancer cells. Onco Targets Ther. 12, 6699–6710 (2019).
5. Huang, W. K. et al. ARHGAP25 inhibits pancreatic adenocarcinoma growth by suppressing glycolysis via AKT/mTOR pathway. Int. J. Biol. Sci. 17, 1808–1820 (2021).